Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

85.74USD
12:40am IST
Price Change (% chg)

$0.42 (+0.49%)
Prev Close
$85.32
Open
$85.71
Day's High
$86.24
Day's Low
$85.32
Volume
65,096
Avg. Vol
196,914
52-wk High
$88.37
52-wk Low
$60.64

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or... (more)

Overall

Beta: 0.56
Market Cap (Mil.): $9,000.73
Shares Outstanding (Mil.): 105.49
Dividend: --
Yield (%): --

Financials

Search Stocks

Edwards wins U.S. nod for next generation Sapien XT heart valve system

- Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

17 Jun 2014

Edwards wins U.S. nod for next generation Sapien XT heart valve system

June 16 - Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

17 Jun 2014

Medtronic settles heart valve patent fight with rival Edwards

- Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market.

20 May 2014

UPDATE 3-Medtronic settles heart valve patent fight with rival Edwards

May 20 - Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market.

20 May 2014

Medtronic settles heart valve patent dispute with Edwards

May 20 - Medtronic Inc on Tuesday said it has agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement agreement that allows Medtronic to continue to sell its CoreValve replacement heart valves.

20 May 2014

Edwards Lifesciences 1st-qtr net profit falls, sales rise 5 pct

April 24 - Medical device maker Edwards Lifesciences Corp said on Thursday quarterly net earnings fell due to higher manufacturing costs, unfavorable foreign exchange rates and a year-earlier gain of $83.6 million related to patent litigation.

25 Apr 2014

U.S. court postpones injunction against Medtronic heart valve

- A U.S. appeals court on Monday postponed an injunction that would have stopped Medtronic Inc from selling its CoreValve heart valve implant in competition with Edwards Lifesciences Corp's Sapien valve product.

22 Apr 2014

U.S. court postpones injunction against Medtronic heart valve

April 21 - A U.S. appeals court on Monday postponed an injunction that would have stopped Medtronic Inc from selling its CoreValve heart valve implant in competition with Edwards Lifesciences Corp's Sapien valve product.

22 Apr 2014

Edwards shares up on injunction against Medtronic heart valve

- Shares of Edwards Lifesciences Corp jumped 13 percent on Monday after a U.S. court temporarily halted sales of competitor Medtronic Inc's heart valve implant that uses a less-invasive procedure to spare patients from open-heart surgery.

14 Apr 2014

REFILE-US STOCKS-Futures tick up after Citi earnings; eyes on Ukraine

NEW YORK, April 14 - U.S. stock index futures edged higher on Monday, following a large selloff last session, with earnings results from Citigroup lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

14 Apr 2014

Competitors

Earnings vs. Estimates

Search Stocks